Tazarotene Gel
Product Images NDC 45802-442
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 45802-442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
6y9-carton (Image 02)
This text is a description and usage instructions for Tazarotene Gel, 0.05%, which is used to treat psoriasis. The dosage is to apply the gel once a day in the evening to the affected areas. It contains Tazarten at 0.05% and Benzyl alcohol as a preservative. The inactive ingredients include ascorbic acid, butylated hydroxytoluene, carbomer homopolymer type B, edetate disodium, ethanol, polyethylene glycol 400, polysorbate 80, purified water. It comes in a 100g size and should be stored between 20°C to 25°C. This product is for dermatological use only and not for ophthalmic use.*
Serialization (Image 03)
7e6-carton (Image 04)
This is a medication information sheet for Tazarotene Gel, used for dermatological purposes such as for acne or psoriasis. The gel should be applied to clean, unaffected skin and should cover the affected area. It is recommended to shower or bathe before application. The dosage and the complete prescription information are mentioned on the packet. It should be kept out of reach of children and stored at a certain temperature. The text may contain errors.*
Serialization-2 (Image 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.